During the past decade, Maubeuge - Polyclinique du Parc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maubeuge - Polyclinique du Parc" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Maubeuge - Polyclinique du Parc" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "ALK Gene Mutation" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Anaplastic Lymphoma Kinase Gene Mutation" (1 trials) and "BRAF Gene Mutation" (1 trials). Many other conditions were trialed in "Maubeuge - Polyclinique du Parc" in a lesser frequency.

Most popular intervention types in "Maubeuge - Polyclinique du Parc" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "Pemetrexed" (2 trials), "Bevacizumab" (1 trials), "Chemotherapy with platine" (1 trials) and "Chemotherapy without Cisplatine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maubeuge - Polyclinique du Parc" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Maubeuge - Polyclinique du Parc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Maubeuge - Polyclinique du Parc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Maubeuge - Polyclinique du Parc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".